Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C8H20NO6P |
Molecular Weight | 257.2213 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[N+](C)(C)CCOP([O-])(=O)OC[C@H](O)CO
InChI
InChIKey=SUHOQUVVVLNYQR-MRVPVSSYSA-N
InChI=1S/C8H20NO6P/c1-9(2,3)4-5-14-16(12,13)15-7-8(11)6-10/h8,10-11H,4-7H2,1-3H3/t8-/m1/s1
Choline alfoscerate (alpha-Glycerylphosphorylcholine or Alpha-GPC) is a nootropic choline-containing phospholipid. Choline alphoscerate increases the release of acetylcholine in rat hippocampus, facilitates learning and memory in experimental animals, improves brain transduction mechanisms and decreases age-dependent structural changes occurring in rat brain areas involved in learning and memory. The compound exerts neuroprotective effects in models of altered cholinergic neurotransmission and of brain vascular injury. In clinical studies choline alphoscerate improved memory and attention impairment, as well as affective and somatic symptoms in dementia disorders. In Europe alpha-GPC is a prescription medication for the treatment of Alzheimer's disease. It is available in two forms; one is taken by mouth, and the other is given as a shot. In the United States alpha-GPC is only available as a dietary supplement, mostly in products promoted to improve memory. Other uses for alpha-GPC include treatment of various kinds of dementia, stroke, and "mini-stroke" (transient ischemic attack, TIA). Alpha-GPC is also used for improving memory, thinking skills, and learning.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0061526 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24156263 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Gliatilin Approved UseUnknown |
|||
Primary | Gliatilin Approved UseUnknown |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
N07AX02
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
||
|
LOINC |
10578-3
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
||
|
WHO-VATC |
QN07AX02
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
||
|
DSLD |
315 (Number of products:313)
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
248-962-2
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY | |||
|
DB04660
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY | |||
|
Alpha-GPC
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY | |||
|
419
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY | |||
|
SUB06216MIG
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY | |||
|
28319-77-9
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY | |||
|
4918
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY | |||
|
100000090092
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY | |||
|
m3482
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY | Merck Index | ||
|
60M22SGW66
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY | |||
|
16870
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY | |||
|
1295786
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY | |||
|
DTXSID70951010
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY | |||
|
5203
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY | |||
|
657272
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY | |||
|
627
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY | |||
|
CHEMBL1567463
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY | |||
|
C166883
Created by
admin on Fri Dec 15 16:17:13 GMT 2023 , Edited by admin on Fri Dec 15 16:17:13 GMT 2023
|
PRIMARY |
ACTIVE MOIETY